Cargando…

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Type 2 diabetes is characterized by a defect in insulin action. The hyperinsulinemic-euglycemic clamp, or insulin clamp, is widely considered the "gold standard" method for assessing insulin action in vivo. During an insulin clamp, hyperinsulinemia is achieved by a constant insulin infusio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayala, Julio E., Bracy, Deanna P., Malabanan, Carlo, James, Freyja D., Ansari, Tasneem, Fueger, Patrick T., McGuinness, Owen P., Wasserman, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MyJove Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308587/
https://www.ncbi.nlm.nih.gov/pubmed/22126863
http://dx.doi.org/10.3791/3188
_version_ 1782227432523169792
author Ayala, Julio E.
Bracy, Deanna P.
Malabanan, Carlo
James, Freyja D.
Ansari, Tasneem
Fueger, Patrick T.
McGuinness, Owen P.
Wasserman, David H.
author_facet Ayala, Julio E.
Bracy, Deanna P.
Malabanan, Carlo
James, Freyja D.
Ansari, Tasneem
Fueger, Patrick T.
McGuinness, Owen P.
Wasserman, David H.
author_sort Ayala, Julio E.
collection PubMed
description Type 2 diabetes is characterized by a defect in insulin action. The hyperinsulinemic-euglycemic clamp, or insulin clamp, is widely considered the "gold standard" method for assessing insulin action in vivo. During an insulin clamp, hyperinsulinemia is achieved by a constant insulin infusion. Euglycemia is maintained via a concomitant glucose infusion at a variable rate. This variable glucose infusion rate (GIR) is determined by measuring blood glucose at brief intervals throughout the experiment and adjusting the GIR accordingly. The GIR is indicative of whole-body insulin action, as mice with enhanced insulin action require a greater GIR. The insulin clamp can incorporate administration of isotopic 2[(14)C]deoxyglucose to assess tissue-specific glucose uptake and [3-(3)H]glucose to assess the ability of insulin to suppress the rate of endogenous glucose appearance (endoRa), a marker of hepatic glucose production, and to stimulate the rate of whole-body glucose disappearance (Rd). The miniaturization of the insulin clamp for use in genetic mouse models of metabolic disease has led to significant advances in diabetes research. Methods for performing insulin clamps vary between laboratories. It is important to note that the manner in which an insulin clamp is performed can significantly affect the results obtained. We have published a comprehensive assessment of different approaches to performing insulin clamps in conscious mice(1) as well as an evaluation of the metabolic response of four commonly used inbred mouse strains using various clamp techniques(2). Here we present a protocol for performing insulin clamps on conscious, unrestrained mice developed by the Vanderbilt Mouse Metabolic Phenotyping Center (MMPC; URL: www.mc.vanderbilt.edu/mmpc). This includes a description of the method for implanting catheters used during the insulin clamp. The protocol employed by the Vanderbilt MMPC utilizes a unique two-catheter system(3). One catheter is inserted into the jugular vein for infusions. A second catheter is inserted into the carotid artery, which allows for blood sampling without the need to restrain or handle the mouse. This technique provides a significant advantage to the most common method for obtaining blood samples during insulin clamps which is to sample from the severed tip of the tail. Unlike this latter method, sampling from an arterial catheter is not stressful to the mouse(1). We also describe methods for using isotopic tracer infusions to assess tissue-specific insulin action. We also provide guidelines for the appropriate presentation of results obtained from insulin clamps.
format Online
Article
Text
id pubmed-3308587
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher MyJove Corporation
record_format MEDLINE/PubMed
spelling pubmed-33085872012-06-28 Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice Ayala, Julio E. Bracy, Deanna P. Malabanan, Carlo James, Freyja D. Ansari, Tasneem Fueger, Patrick T. McGuinness, Owen P. Wasserman, David H. J Vis Exp Medicine Type 2 diabetes is characterized by a defect in insulin action. The hyperinsulinemic-euglycemic clamp, or insulin clamp, is widely considered the "gold standard" method for assessing insulin action in vivo. During an insulin clamp, hyperinsulinemia is achieved by a constant insulin infusion. Euglycemia is maintained via a concomitant glucose infusion at a variable rate. This variable glucose infusion rate (GIR) is determined by measuring blood glucose at brief intervals throughout the experiment and adjusting the GIR accordingly. The GIR is indicative of whole-body insulin action, as mice with enhanced insulin action require a greater GIR. The insulin clamp can incorporate administration of isotopic 2[(14)C]deoxyglucose to assess tissue-specific glucose uptake and [3-(3)H]glucose to assess the ability of insulin to suppress the rate of endogenous glucose appearance (endoRa), a marker of hepatic glucose production, and to stimulate the rate of whole-body glucose disappearance (Rd). The miniaturization of the insulin clamp for use in genetic mouse models of metabolic disease has led to significant advances in diabetes research. Methods for performing insulin clamps vary between laboratories. It is important to note that the manner in which an insulin clamp is performed can significantly affect the results obtained. We have published a comprehensive assessment of different approaches to performing insulin clamps in conscious mice(1) as well as an evaluation of the metabolic response of four commonly used inbred mouse strains using various clamp techniques(2). Here we present a protocol for performing insulin clamps on conscious, unrestrained mice developed by the Vanderbilt Mouse Metabolic Phenotyping Center (MMPC; URL: www.mc.vanderbilt.edu/mmpc). This includes a description of the method for implanting catheters used during the insulin clamp. The protocol employed by the Vanderbilt MMPC utilizes a unique two-catheter system(3). One catheter is inserted into the jugular vein for infusions. A second catheter is inserted into the carotid artery, which allows for blood sampling without the need to restrain or handle the mouse. This technique provides a significant advantage to the most common method for obtaining blood samples during insulin clamps which is to sample from the severed tip of the tail. Unlike this latter method, sampling from an arterial catheter is not stressful to the mouse(1). We also describe methods for using isotopic tracer infusions to assess tissue-specific insulin action. We also provide guidelines for the appropriate presentation of results obtained from insulin clamps. MyJove Corporation 2011-11-16 /pmc/articles/PMC3308587/ /pubmed/22126863 http://dx.doi.org/10.3791/3188 Text en Copyright © 2011, Journal of Visualized Experiments http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Medicine
Ayala, Julio E.
Bracy, Deanna P.
Malabanan, Carlo
James, Freyja D.
Ansari, Tasneem
Fueger, Patrick T.
McGuinness, Owen P.
Wasserman, David H.
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
title Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
title_full Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
title_fullStr Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
title_full_unstemmed Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
title_short Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
title_sort hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308587/
https://www.ncbi.nlm.nih.gov/pubmed/22126863
http://dx.doi.org/10.3791/3188
work_keys_str_mv AT ayalajulioe hyperinsulinemiceuglycemicclampsinconsciousunrestrainedmice
AT bracydeannap hyperinsulinemiceuglycemicclampsinconsciousunrestrainedmice
AT malabanancarlo hyperinsulinemiceuglycemicclampsinconsciousunrestrainedmice
AT jamesfreyjad hyperinsulinemiceuglycemicclampsinconsciousunrestrainedmice
AT ansaritasneem hyperinsulinemiceuglycemicclampsinconsciousunrestrainedmice
AT fuegerpatrickt hyperinsulinemiceuglycemicclampsinconsciousunrestrainedmice
AT mcguinnessowenp hyperinsulinemiceuglycemicclampsinconsciousunrestrainedmice
AT wassermandavidh hyperinsulinemiceuglycemicclampsinconsciousunrestrainedmice